SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsArchive2026-11-12

Thu, Nov 12, 2026 - Page 70

13819 indexed SquawkNews stories from this UTC day. Showing 8281-8400.

EQUITY 5982EARNINGS 4842FX 653NEWS 460CENTRAL_BANK 417MACRO 293GEOPOLITICS 273REGULATION 219MNA 175RATES 149ENERGY 148COMMODITIES 145
L Legence 3Q EPS $1.15 >LGN Legence 3Q EPS $1.15 >LGN EARNINGS | Nov 12, 2026, 12:06 PM UTC L JD.com Seeks to Lead European Electronics Retail With Ceconomy Deal JD.com is seeking to lead Europe's online electronics retail through a deal with Ceconomy; the headline provides no deal terms or status. MNA | Nov 12, 2026, 12:06 PM UTC L BRIEF-IGL Spirits Limited Says Sept-Quarter Profit 612 Million Rupees BRIEF-IGL Spirits Limited Says Sept-Quarter Profit 612 Million Rupees Nov 12 (Reuters) - IGL Spirits EARNINGS | Nov 12, 2026, 12:06 PM UTC L DPC Holdings 3Q Rev $308.1M >DPC DPC Holdings 3Q Rev $308.1M >DPC EQUITY | Nov 12, 2026, 12:06 PM UTC L NIQ GLOBAL INTELLIGENCE OUTLOOK Q4 ADJ EPS $0.43 — $0.47 NIQ GLOBAL INTELLIGENCE OUTLOOK Q4 ADJ EPS $0.43 — $0.47 EARNINGS | Nov 12, 2026, 12:06 PM UTC L EnCore Energy 3Q Loss/Shr 17c >EU EnCore Energy 3Q Loss/Shr 17c >EU EQUITY | Nov 12, 2026, 12:06 PM UTC L ADI GLOBAL DISTRIBUTION - ESTIMATES FULL-YEAR 2026 NON-GAAP ADJ STANDALONE EBITDA $230 MLN-$240 MLN ADI GLOBAL DISTRIBUTION - ESTIMATES FULL-YEAR 2026 NON-GAAP ADJ STANDALONE EBITDA $230 MLN-$240 MLN EQUITY | Nov 12, 2026, 12:06 PM UTC H Mobility Global beats by $0.02, reports revs in-line; reaffirms FY26 revs guidance Reports Q3 (Sep) earnings of $0.40 per share, excluding non-recurring items, $0.02 better than the F EARNINGS | Nov 12, 2026, 12:06 PM UTC M HSBC Plans SRTs Tied to $7 Billion in US and Asian Loans Bloomberg News reports that HSBC plans significant risk transfers tied to $7 billion of US and Asian corporate loans. RATES | Nov 12, 2026, 12:06 PM UTC H *-- Earnings Flash (MBGL) Mobility Global Inc. Reports Q3 Revenue $478.0M, vs. FactSet Est of $475.1M *-- Earnings Flash (MBGL) Mobility Global Inc. Reports Q3 Revenue $478.0M, vs. EARNINGS | Nov 12, 2026, 12:06 PM UTC L EnCore Energy 3Q Rev $16.7M >EU EnCore Energy 3Q Rev $16.7M >EU EQUITY | Nov 12, 2026, 12:06 PM UTC L NIQ GLOBAL INTELLIGENCE OUTLOOK Q4 REVENUE $1,198M — $1,202M NIQ GLOBAL INTELLIGENCE OUTLOOK Q4 REVENUE $1,198M — $1,202M EARNINGS | Nov 12, 2026, 12:06 PM UTC L ADI GLOBAL DISTRIBUTION - ESTIMATES FULL-YEAR 2026 NET REVENUE $4.91 BLN-$4.93 BLN ADI GLOBAL DISTRIBUTION - ESTIMATES FULL-YEAR 2026 NET REVENUE $4.91 BLN-$4.93 BLN EARNINGS | Nov 12, 2026, 12:06 PM UTC L AJ Bell Says WH Smith Needs Stronger Cash Flow to Restore Investor Credibility AJ Bell’s Russ Mould says WH Smith needs to improve cash flow. The retailer reported higher fiscal 2026 revenue and free cash flow of £52 million, down from £63 million. EQUITY | Nov 12, 2026, 12:06 PM UTC L JD.com CEO Says No Current Plans for European Acquisitions The JD.com Worldwide CEO said the company has no current plans for further acquisitions in Europe but did not rule them out in the future. EQUITY | Nov 12, 2026, 12:06 PM UTC H *-- Earnings Flash (GASX.TO) NG Energy International Reports Q3 Sales $18.3M *-- Earnings Flash (GASX.TO) NG Energy International Reports Q3 Sales $18.3M EARNINGS | Nov 12, 2026, 12:06 PM UTC M PLAYSTUDIOS launches up to $15 million share repurchase tender offer PLAYSTUDIOS commenced a modified Dutch auction tender offer to repurchase up to $15 million of its Class A common stock. EQUITY | Nov 12, 2026, 12:06 PM UTC L JD.com CEO Says Company Wants Europe Electronics Retail Platform With Ceconomy EQUITY | Nov 12, 2026, 12:06 PM UTC L BRIEF-Century Therapeutics Q3 Net Income USD -23.453 Million Vs. IBES Estimate USD -24.3 Million Nov 12 (Reuters) - Century Therapeutics Q3 operating income USD -25.206 million vs. IBES estimate USD -24.7 million. FX | Nov 12, 2026, 12:06 PM UTC L BRIEF-Absci Q3 Revenue USD 304 Thousand Vs. IBES Estimate USD 727.1 Thousand Nov 12 (Reuters) - Absci Q3 operating expenses USD 35.298 million. EARNINGS | Nov 12, 2026, 12:06 PM UTC M ADI Global Distribution Lowers Full-Year 2026 Outlook ADI Global Distribution lowered its full-year 2026 outlook, citing Q3 performance and weakness in exclusive brands. EARNINGS | Nov 12, 2026, 12:06 PM UTC L BRIEF-Century Therapeutics Q3 Net Income USD -23.453 Million Vs. IBES Estimate USD -24.3 Million BRIEF-Century Therapeutics Q3 Net Income USD -23.453 Million Vs. IBES Estimate USD -24.3 Million Nov FX | Nov 12, 2026, 12:06 PM UTC L BRIEF-Absci Q3 Revenue USD 304 Thousand Vs. IBES Estimate USD 727.1 Thousand BRIEF-Absci Q3 Revenue USD 304 Thousand Vs. IBES Estimate USD 727.1 Thousand Nov 12 (Reuters) - Absc EARNINGS | Nov 12, 2026, 12:06 PM UTC M Alkermes Agreement Resolves Lybalvi Patent Lawsuit An agreement resolves the patent lawsuit covering all dosage strengths of Lybalvi, according to an SEC filing. EQUITY | Nov 12, 2026, 12:06 PM UTC L AITX RAD Billed Recurring Monthly Revenue Rises 12.4% in Two Months EQUITY | Nov 12, 2026, 12:06 PM UTC L Cyngn (CYN) Q3 Revenue Rose To $156.5K; Net Loss Narrowed To $6.0M Q3 2026 revenue was $156.5K versus $70.0K in Q3 2025, and net loss was $6.0M versus $8.4M. Cash and short-term investments totaled $34.9M at September 30, 2026, versus $34.7M at December 31, 2025.Material DetailsContext EARNINGS | Nov 12, 2026, 12:06 PM UTC L Chevron to Restart Iowa Biodiesel Plant Under Landus Feedstock Deal ENERGY | Nov 12, 2026, 12:06 PM UTC L NIQ GLOBAL INTELLIGENCE OUTLOOK FY ADJ EPS $1.16 — $1.20 NIQ GLOBAL INTELLIGENCE OUTLOOK FY ADJ EPS $1.16 — $1.20 EARNINGS | Nov 12, 2026, 12:06 PM UTC L Moderna Anticipates About $9 Billion in Total Liquidity at 2026 Year-End EQUITY | Nov 12, 2026, 12:06 PM UTC L Playstudios Sets Share Repurchase Price Range at $4.30-$5.50 Playstudios shares are to be repurchased for no less than $4.30 and no more than $5.50 each. EQUITY | Nov 12, 2026, 12:06 PM UTC L Cardinal Infrastructure CFO Mike Rowe to Resign Once Successor Is Appointed EQUITY | Nov 12, 2026, 12:05 PM UTC L Citigroup Analysts Cut Nvidia Price Target to $225 From $285 Citigroup analysts Atif Malik and Papa Sylla lowered their Nvidia price target, citing leadership-transition concerns related to Jensen Huang's central role in strategy. EQUITY | Nov 12, 2026, 12:05 PM UTC L Sprott Physical Gold and Silver Trust Fees Rise to USD 26.8 Million The trust's management fees for nine months rose to USD 26.8 million. COMMODITIES | Nov 12, 2026, 12:05 PM UTC L FERMI INC: Q3 NET LOSS PER SHARE $0.22 FERMI INC: Q3 NET LOSS PER SHARE $0.22 EQUITY | Nov 12, 2026, 12:05 PM UTC L Cyngn Reports 2026 3rd Quarter Financial Results Enterprise adoption advances with a follow-on Fortune 100 order, record monthly fleet activity, and a completed SOC 2 Type II examinationRecent Operating HighlightsMOUNTAIN VIEW, Calif., Nov. 12, 2026 // -- Cyngn (NASDAQ EQUITY | Nov 12, 2026, 12:05 PM UTC L FICO Survey Finds 1.1% of Financial Firms Broadly Deploy AI Agents EQUITY | Nov 12, 2026, 12:05 PM UTC L Standard Nuclear Q3 Revenue Rises to $6.0 Million; Gross Profit Reaches $1.8 Million Standard Nuclear reported third-quarter 2026 revenue of $6.0 million, up from $0.9 million a year earlier, and gross profit of $1.8 million. The company recorded a net loss of $13.1 million, including $10.3 million of sh EARNINGS | Nov 12, 2026, 12:05 PM UTC L Aebi Schmidt Q3 Sales Rise 4.6%; Adjusted EBITDA Reaches $44.2 Million Aebi Schmidt reported third-quarter 2026 net sales of $493.1 million, up 4.6% year over year, and adjusted EBITDA of $44.2 million, up 4.9%. Net income rose to $10.8 million from $1.2 million a year earlier. The company EQUITY | Nov 12, 2026, 12:05 PM UTC H *-- Earnings Flash (BN) Brookfield Corporation Reports Q3 Revenue $20.69B *-- Earnings Flash (BN) Brookfield Corporation Reports Q3 Revenue $20.69B EARNINGS | Nov 12, 2026, 12:05 PM UTC L Ocumetics Technology Corp. (OTC) Expects Group Two Lens Results by Year-End Ocumetics says clinical, regulatory and manufacturing requirements for Group Two first-in-human lens implantations are complete and surgeries are imminent. Initial patient results are expected by year-end; potential nego EQUITY | Nov 12, 2026, 12:05 PM UTC H *-- Earnings Flash (XLY.TO) Auxly Cannabis Group Reports Q3 Revenue CA$49.5M, vs. FactSet Est of CA$45.8M *-- Earnings Flash (XLY.TO) Auxly Cannabis Group Reports Q3 Revenue CA$49.5M, vs. FactSet Est of CA$45.8M EARNINGS | Nov 12, 2026, 12:05 PM UTC L Kiora Pharmaceuticals Reports Q3 2026 Results, Advances KIO-401 Development Kiora Pharmaceuticals reported third-quarter 2026 collaboration revenue of $1.0 million and a net loss of $1.75 million, compared with no revenue and net income of $26,806 in the year-earlier quarter. The company ended S EARNINGS | Nov 12, 2026, 12:05 PM UTC L Table: TSEC 3Q Net Loss NT$469.9M Vs NT$620.2M TSEC Corp. - Taiwan 3rd Quarter ended Sept. 30: Figures in New Taiwan dollars. 2026 2025 Revenue NT$222,502,000 NT$341,338,000 Pretax Profit (NT$468,326,000) (NT$548,804,000) Net Profit… EARNINGS | Nov 12, 2026, 12:05 PM UTC L Sprott Physical Copper Trust Reports USD 735,000 in Nine-Month Management Fees The trust's management fees rose to USD 735,000 over nine months. COMMODITIES | Nov 12, 2026, 12:05 PM UTC L GFL Environmental Issues 6,219,896 Shares in Preferred Conversion GFL Environmental issued 6,219,896 subordinate voting shares upon conversion of preferred shares. EQUITY | Nov 12, 2026, 12:05 PM UTC L Legence Sees 4Q Rev $1.26B-$1.30B >LGN Legence Sees 4Q Rev $1.26B-$1.30B >LGN EQUITY | Nov 12, 2026, 12:05 PM UTC L NIQ GLOBAL INTELLIGENCE OUTLOOK FY REVENUE $4,513M - $4,520M NIQ GLOBAL INTELLIGENCE OUTLOOK FY REVENUE $4,513M - $4,520M EARNINGS | Nov 12, 2026, 12:05 PM UTC L Sound Point Meridian declares Q4 FY2027 distributions, reports $4.1 million Q2 loss Sound Point Meridian declared monthly common and preferred distributions for Q4 FY2027 and reported a $4.1 million net loss for its second fiscal quarter.Key Highlights:Original SEC Filing: Sound Point Meridian Capital, REGULATION | Nov 12, 2026, 12:05 PM UTC L Deutsche Bank raises RPM International price target to $125 from $115 EQUITY | Nov 12, 2026, 12:05 PM UTC L Deutsche Bank raises Ulta Beauty price target to $723 from $671 EQUITY | Nov 12, 2026, 12:05 PM UTC L D-Wave Quantum Named a Gartner Market Shaper in Quantum Computing D-Wave Quantum said it was recognized as a Market Shaper in Gartner’s November 2026 Emerging Market Quadrant for Quantum Computing. EQUITY | Nov 12, 2026, 12:05 PM UTC L Deutsche Bank raises Walmart price target to $147 from $136 EQUITY | Nov 12, 2026, 12:05 PM UTC L Deutsche Bank raises Grocery Outlet target to $13 from $9 EQUITY | Nov 12, 2026, 12:05 PM UTC L Deutsche Bank raises General Dynamics price target to $360 from $353 EQUITY | Nov 12, 2026, 12:05 PM UTC L May Mobility Plans Autonomous Volkswagen ID. Buzz Rollout to Global Robotaxi Platforms May Mobility plans to bring autonomous Volkswagen ID. Buzz vehicles to global robotaxi platforms. EQUITY | Nov 12, 2026, 12:05 PM UTC L Lantronix and Latent AI Bring Target Tracking to Group 1 UAS EQUITY | Nov 12, 2026, 12:05 PM UTC L ADI Announces Third Quarter 2026 Financial Results and Updates Full-Year Outlook ADI Global Distribution Inc. (“ADI”) (NYSE:ADIG), a leading global specialty distributor of low-voltage products, today announced financial results for its third quarter 2026 ended October 3, 2026 and updated its outlook EQUITY | Nov 12, 2026, 12:05 PM UTC L Century Therapeutics Reports Third Quarter 2026 Financial Results and Business Updates CNTY-813, an iPSC-derived islet replacement therapy for T1D, presented new nonclinical data at the 6 EQUITY | Nov 12, 2026, 12:05 PM UTC L ABSCI Q3 NET INCOME USD -33.3 MILLION ABSCI Q3 NET INCOME USD -33.3 MILLION FX | Nov 12, 2026, 12:05 PM UTC L CENTURY THERAPEUTICS Q3 OPERATING INCOME USD -25.206 MILLION VS. IBES ESTIMATE USD -24.7 MILLION CENTURY THERAPEUTICS Q3 OPERATING INCOME USD -25.206 MILLION VS. IBES ESTIMATE USD -24.7 MILLION FX | Nov 12, 2026, 12:05 PM UTC L Absci Reports Business Updates and Third Quarter 2026 Financial and Operating Results ABS-201™ HEADLINE™ trial progressing on track; 13-week interim proof-of-concept data for pattern hai EQUITY | Nov 12, 2026, 12:05 PM UTC L Cyngn Reports 2026 3rd Quarter Financial Results Enterprise adoption advances with a follow-on Fortune 100 order, record monthly fleet activity, and EQUITY | Nov 12, 2026, 12:05 PM UTC L ABSCI REPORTS BUSINESS UPDATES AND THIRD QUARTER 2026 FINANCIAL AND OPERATING RESULTS ABSCI REPORTS BUSINESS UPDATES AND THIRD QUARTER 2026 FINANCIAL AND OPERATING RESULTS EQUITY | Nov 12, 2026, 12:05 PM UTC L CENTURY THERAPEUTICS Q3 NET INCOME USD -23.453 MILLION VS. IBES ESTIMATE USD -24.3 MILLION CENTURY THERAPEUTICS Q3 NET INCOME USD -23.453 MILLION VS. IBES ESTIMATE USD -24.3 MILLION FX | Nov 12, 2026, 12:05 PM UTC L ADI ANNOUNCES THIRD QUARTER 2026 FINANCIAL RESULTS AND UPDATES FULL-YEAR OUTLOOK ADI ANNOUNCES THIRD QUARTER 2026 FINANCIAL RESULTS AND UPDATES FULL-YEAR OUTLOOK EQUITY | Nov 12, 2026, 12:05 PM UTC L ADI Announces Third Quarter 2026 Financial Results and Updates Full-Year Outlook Net revenue of $1,306 million, up 9% year-over-year; average daily sales increased 5% Gross margin o EARNINGS | Nov 12, 2026, 12:05 PM UTC L ABSCI Q3 PRETAX PROFIT USD -33.282 MILLION ABSCI Q3 PRETAX PROFIT USD -33.282 MILLION EARNINGS | Nov 12, 2026, 12:05 PM UTC L CENTURY THERAPEUTICS REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND BUSINESS UPDATES CENTURY THERAPEUTICS REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND BUSINESS UPDATES EQUITY | Nov 12, 2026, 12:05 PM UTC L ABSCI Q3 BASIC EPS USD -0.19 ABSCI Q3 BASIC EPS USD -0.19 EARNINGS | Nov 12, 2026, 12:05 PM UTC L ABSCI Q3 OPERATING INCOME USD -34.994 MILLION ABSCI Q3 OPERATING INCOME USD -34.994 MILLION FX | Nov 12, 2026, 12:05 PM UTC L CENTURY THERAPEUTICS Q3 BASIC EPS USD -0.11 CENTURY THERAPEUTICS Q3 BASIC EPS USD -0.11 EARNINGS | Nov 12, 2026, 12:05 PM UTC L Absci Reports Business Updates and Third Quarter 2026 Financial and Operating Results Absci Reports Business Updates and Third Quarter 2026 Financial and Operating Results ABS-201™ HEADL EQUITY | Nov 12, 2026, 12:05 PM UTC L CYNGN REPORTS 2026 3RD QUARTER FINANCIAL RESULTS CYNGN REPORTS 2026 3RD QUARTER FINANCIAL RESULTS EQUITY | Nov 12, 2026, 12:05 PM UTC L Century Therapeutics Reports Third Quarter 2026 Financial Results and Business Updates Century Therapeutics Reports Third Quarter 2026 Financial Results and Business Updates CNTY-813, an EQUITY | Nov 12, 2026, 12:05 PM UTC M HSBC Plans SRTs Tied to $7 Billion in US, Asian Corporate Loans RATES | Nov 12, 2026, 12:04 PM UTC L Trump Threatens To Double Mexico Tariffs If It Does Not Stop Caravans, Via DBnews.com READ HERE NEWS | Nov 12, 2026, 12:04 PM UTC L Stoxx 600 Reaches Record as Wall Street Awaits Nvidia A market update says the pan-European Stoxx 600 touched a record, while Wall Street remained focused on Nvidia. The available text is truncated. EQUITY | Nov 12, 2026, 12:04 PM UTC L Bristol Myers Squibb Announces R&D Organization Changes EQUITY | Nov 12, 2026, 12:04 PM UTC L DarioHealth Q3 net loss narrows 15% year-over-year to $8.85 million DarioHealth Q3 net loss narrows 15% year-over-year to $8.85 million DarioHealth's third-quarter EQUITY | Nov 12, 2026, 12:04 PM UTC L NetEase Publishes Third-Quarter 2026 Holdings Report NetEase disclosed two portfolio holdings, according to the report. EQUITY | Nov 12, 2026, 12:04 PM UTC H OCTAVE INTELLIGENCE - FULL YEAR 2026 TOTAL REVENUE GUIDANCE $1.64 BLN-$1.66 BLN OCTAVE INTELLIGENCE - FULL YEAR 2026 TOTAL REVENUE GUIDANCE $1.64 BLN-$1.66 BLN EARNINGS | Nov 12, 2026, 12:04 PM UTC L SICO - Q3 SAW LOWER BROKERAGE INCOME SICO - Q3 SAW LOWER BROKERAGE INCOME EQUITY | Nov 12, 2026, 12:04 PM UTC H *-- GUIDANCE: (NIQ) NIQ Global Intelligence plc Expects Q4 Revenue $1.20B *-- GUIDANCE: (NIQ) NIQ Global Intelligence plc Expects Q4 Revenue $1.20B EARNINGS | Nov 12, 2026, 12:04 PM UTC H OCTAVE INTELLIGENCE - Q4 2026 TOTAL REVENUE GUIDANCE $440 MLN-$460 MLN OCTAVE INTELLIGENCE - Q4 2026 TOTAL REVENUE GUIDANCE $440 MLN-$460 MLN EARNINGS | Nov 12, 2026, 12:04 PM UTC M Wolverine World Wide Raises 2026 Guidance as Q3 Earnings, Revenue Rise Wolverine World Wide reported higher adjusted earnings and revenue for the third quarter and raised its 2026 guidance. EQUITY | Nov 12, 2026, 12:04 PM UTC H *-- Earnings Flash (LCFS.TO) Tidewater Renewables Reports Q3 Revenue CA$239.9M *-- Earnings Flash (LCFS.TO) Tidewater Renewables Reports Q3 Revenue CA$239.9M EARNINGS | Nov 12, 2026, 12:04 PM UTC L Wolfe downgrades 3M to Peer Perform from Outperform EQUITY | Nov 12, 2026, 12:04 PM UTC H *-- GUIDANCE: (NIQ) NIQ Global Intelligence plc Expects Q4 Adjusted EPS Range $0.43 - $0.47 *-- GUIDANCE: (NIQ) NIQ Global Intelligence plc Expects Q4 Adjusted EPS Range $0.43 - $0.47 EARNINGS | Nov 12, 2026, 12:04 PM UTC H *-- Earnings Flash (NIQ) NIQ Global Intelligence plc Reports Q3 Revenue $1.12B, vs. FactSet Est of $1.11B *-- Earnings Flash (NIQ) NIQ Global Intelligence plc Reports Q3 Revenue $1.12B, vs. FactSet Est of $1.11B EARNINGS | Nov 12, 2026, 12:04 PM UTC H *-- Earnings Flash (NIQ) NIQ Global Intelligence plc Posts Q3 Adjusted EPS $0.30 per Share, vs. FactSet Est of $0.23 *-- Earnings Flash (NIQ) NIQ Global Intelligence plc Posts Q3 Adjusted EPS $0.30 per Share, vs. FactSet Est of $0.23 EARNINGS | Nov 12, 2026, 12:04 PM UTC H *--Earnings Flash (PHVS) Pharvaris Posts Q3 Loss 0.67 Euros a Share, vs. FactSet Est of 0.77 Euro Loss *--Earnings Flash (PHVS) Pharvaris Posts Q3 Loss 0.67 Euros a Share, vs. FactSet Est of 0.77 Euro Loss EARNINGS | Nov 12, 2026, 12:04 PM UTC M Tidewater Midstream Raises FY Adjusted EBITDA Outlook to C$300M–C$320M EARNINGS | Nov 12, 2026, 12:04 PM UTC L Lithium Americas returns to Q3 profit on financial gains OverviewOutlookResult DriversCompany press release:Key DetailsAnalyst CoverageReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feed EARNINGS | Nov 12, 2026, 12:04 PM UTC L Lithium Americas returns to Q3 profit on financial gains Lithium Americas returns to Q3 profit on financial gains Overview U.S. lithium developer reported Q3 EARNINGS | Nov 12, 2026, 12:04 PM UTC L NATO's Rutte Reports Positive Developments in Ukraine Talks NATO Secretary General Mark Rutte said there were positive developments in Ukraine talks. GEOPOLITICS | Nov 12, 2026, 12:04 PM UTC L Legence 3Q Rev $1.31B >LGN Legence 3Q Rev $1.31B >LGN EQUITY | Nov 12, 2026, 12:04 PM UTC L Moderna Targets ~USD 4B Cash Costs In 2027 Moderna Targets ~USD 4B Cash Costs In 2027 NEWS | Nov 12, 2026, 12:03 PM UTC L TScan Therapeutics Reports Q3 2026 Revenue of $0.6M and Net Loss of $33.1M TScan Therapeutics reported third-quarter 2026 revenue of $0.6 million and a net loss of $33.1 million. The company is prioritizing in vivo-engineered TCR-T therapies for solid tumors, with its first clinical candidate t EARNINGS | Nov 12, 2026, 12:03 PM UTC L Kardigan Reports Q3 2026 Net Loss of $58.6 Million, Advances Clinical Programs Kardigan reported a third-quarter 2026 net loss of $58.6 million, compared with $60.2 million a year earlier, and ended September with $591.4 million in cash, cash equivalents and investments. The company completed enrol EQUITY | Nov 12, 2026, 12:03 PM UTC L Parabilis Medicines 3Q Rev $2.1M >PBLS Parabilis Medicines 3Q Rev $2.1M >PBLS EQUITY | Nov 12, 2026, 12:03 PM UTC L Broadwind 3Q Cont Ops Loss/Shr 4c >BWEN Broadwind 3Q Cont Ops Loss/Shr 4c >BWEN EQUITY | Nov 12, 2026, 12:03 PM UTC L Rocky Mountain Chocolate Factory CFO Carrie E. Cass to Resign Carrie E. Cass will resign after the company files its quarterly report for the quarter ended November 30, 2026. EQUITY | Nov 12, 2026, 12:03 PM UTC L Codere Online Luxembourg, S.A. (CDRO) Q3 Revenue Rises 31% to €62.6M Codere Online Luxembourg, S.A. reported preliminary, unaudited Q3 revenue of €62.6M, up 31%, and Adjusted EBITDA of €4.2M, up 45%. It reaffirmed its 2026 outlook; Q3 benefited from the World Cup's final stages and favora EARNINGS | Nov 12, 2026, 12:03 PM UTC L Abaxx Technologies Inc. (ABXX) Q3 Net Loss Narrows to $20.4M From $28.8M in Q2 Abaxx Technologies reported a Q3 2026 net loss of $20.4M, down from $28.8M in Q2. Net cash spend was $16.8M, up 2.8% from Q2; quarter-end cash and cash equivalents were $68.1M.Material DetailsContext by AI AnalystThe res EQUITY | Nov 12, 2026, 12:03 PM UTC L Baker Hughes and TPAO Explore Geothermal Power Opportunities in Türkiye Baker Hughes and Türkiye Petrolleri Anonim Ortaklığı announced an agreement to explore opportunities for enhanced geothermal power generation. ENERGY | Nov 12, 2026, 12:03 PM UTC L Cybersecurity Software Earnings Reports Continue Through Nov. 18 A commentary recap says cybersecurity software companies have reported quarterly results and introduced AI security products over the past two weeks, with another report scheduled for Nov. 18. EQUITY | Nov 12, 2026, 12:03 PM UTC L Abaxx Technologies Inc. Reports Third Quarter 2026 Results TORONTO, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Abaxx Technologies Inc. TSX:ABXXOTCQX:ABXXF (“Abaxx” or the “Company”), a financial software and market infrastructure company, majority shareholder of Abaxx Singapore Pte Ltd., EQUITY | Nov 12, 2026, 12:03 PM UTC L Traws Pharma Reports Phase 2a Ratutrelvir Results and Completes Tivoxavir Tablet Study Traws Pharma reported final Phase 2a results for ratutrelvir in COVID-19 and completed a bridging study of its tivoxavir marboxil tablet.Key Highlights:Original SEC Filing: Traws Pharma, Inc. [ TRAW ] - 8-K - Nov. 12, 20 REGULATION | Nov 12, 2026, 12:03 PM UTC L SOUND POINT MERIDIAN CAPITAL - Q2 NET INVESTMENT INCOME WAS $5.80 MLN, OR $0.28 PER COMMON SHARE SOUND POINT MERIDIAN CAPITAL - Q2 NET INVESTMENT INCOME WAS $5.80 MLN, OR $0.28 PER COMMON SHARE EQUITY | Nov 12, 2026, 12:03 PM UTC L American Shared Hospital Services (AMS) Q3 Revenue Rose 6.3%, but Net Loss Widened to $620K Q3 2026 revenue rose 6.3% to $7.6M from $7.2M, while net loss widened to $620K from $17K. Nine-month revenue rose 13.7% to $23.1M from $20.4M; net loss was $1.7M versus $922K.Material DetailsContext by AI AnalystThis is EARNINGS | Nov 12, 2026, 12:03 PM UTC L Aeluma (ALMU) Agrees to Buy MOCVD System for Photonics Expansion Aeluma executed an agreement to purchase an AIXTRON G10-AsP MOCVD system configured for its processes, supporting development and manufacturing capacity for its non-InP photonics platform. The release gives no purchase p EQUITY | Nov 12, 2026, 12:03 PM UTC L Traws Pharma Reports Final Phase 2a Results for Ratutrelvir in COVID-infected Subjects, Showing Fewer Treatment-Related Adverse Events and N Tivoxavir Marboxil Tablet Bridging Study Completed in Preparation for Additional StudiesNEWTOWN, Pa., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Traws Pharma, Inc. (NASDAQ: TRAW, “Traws Pharma,” “Traws” or “the Company”), a clini EQUITY | Nov 12, 2026, 12:03 PM UTC L Galliford Try reaffirms outlook on robust start to the year Updating investors ahead of the annual general meeting, the FTSE 250 construction group said the "strong" operational performance it had seen in the year to June had continued into the first half of the current year.In p EQUITY | Nov 12, 2026, 12:03 PM UTC L Putin to hold security council meeting today - IFX Putin to hold security council meeting today - IFX NEWS | Nov 12, 2026, 12:03 PM UTC L Cardiff Oncology Reports Third Quarter 2026 Results and Provides Business Update Phase 2 trial remains ongoing, with median PFS not reached in the 30 mg onvansertib + FOLFIRI/bev arm versus median PFS of approximately 11 months in the combined SoC armsAll patients remaining in the 30 mg onvansertib + EQUITY | Nov 12, 2026, 12:03 PM UTC L Pelthos Therapeutics Announces Third Quarter 2026 Financial Results and Provides Business Update Zelsuvmi® net product revenue grew 114% to $15.2 million during the third quarter of 2026 from $7.1 million in the third quarter of 202512,384 Zelsuvmi units were dispensed by 4,942 unique prescribers during the third qu EARNINGS | Nov 12, 2026, 12:03 PM UTC H Aveanna Healthcare Holdings Announces Third Quarter Financial Results and Revised 2026 Guidance ATLANTA, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. NASDAQ:AVAH, a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today anno EARNINGS | Nov 12, 2026, 12:03 PM UTC L Broadwind 3Q Rev $22.3M >BWEN Broadwind 3Q Rev $22.3M >BWEN EQUITY | Nov 12, 2026, 12:03 PM UTC L TScan Therapeutics, Inc. (TCRX) Reports Q3 Net Loss of $33.1M; Cash Runway Into Q4 2027 TScan reported Q3 2026 revenue of $0.6M versus $2.5M a year earlier and a net loss of $33.1M versus $35.7M. Cash and cash equivalents were $73.0M at September 30, excluding $5.0M restricted cash; the company expects fund EARNINGS | Nov 12, 2026, 12:03 PM UTC L Acurx Pharmaceuticals 3Q Loss/Shr 49c >ACXP Acurx Pharmaceuticals 3Q Loss/Shr 49c >ACXP EQUITY | Nov 12, 2026, 12:03 PM UTC